Dan Berenson
Senior Managing Director, Healthcare Mergers & AcquisitionsDan Berenson is a Senior Managing Director focused at Leerink Partners focused on Biopharma Mergers & Acquisitions.
Prior to joining the Firm in 2019, Dan spent the early part of his career at Centerview Partners and Guggenheim Securities where he executed multiple biopharma transactions. Dan has extensive experience advising both public and private biopharma companies on matters involving mergers and acquisitions, asset sales and licensing transactions. During his 15 years as a healthcare M&A professional, he has advised on >30 strategic transactions, including Assertio’s acquisition of Spectrum Pharmaceuticals, Rocket Pharmaceuticals’ acquisition of Renovacor, Zogenix’s sale to UCB, Dermira’s sale to Eli Lilly and Ambit’s sale to Daiichi Sankyo.
He earned an M.B.A. from Yale School of Management and a B.A. from Emory College.
